Chinese Phase III Clinical Trials of rhNRG-1 are Recruiting Patients
2011-01-11
Zensun's first-in-class innovative drug rhNRG-1 are now underging Chinese phase III clinical trials. So far, there are 70 hospitals participating in this study. At the same, US phase II clinical trial of rhNRG-1 is recruiting patients.
More
Zensun is Collaborating with The Leibniz-Institut für Alternsforschung-Fritz-Lipmann-Institute.V. to Conduct a Preclinical Study of Neucardin® (recombinant human Neuregulin-1) for The Treatment of Schwannomas
ZENSUN ANNOUNCES THE INVESTIGATION OF NEUCARDIN FOR CHRONIC HEART FAILURE RECEIVES FAST TRACK DESIGNATION FROM THE US FDA
An International Multi-center Phase III Clinical Trial of Recombinant Human Neuregulin-1 is going to